Company / R&D Expense
Cosmos Health Inc. R&D Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$519.4K
FY2025
5-year range
$164.9K / $533.3K
FY2023-FY2025
Trend
-2.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $164,859 to $519,363 over the past 2 years.
Based on SEC 10-K filings.
$519,363 in FY2025.
Improved from $164,859 to $519,363 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d expense decreased 2.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $519.4K | -2.6% |
| FY2024 | $533.3K | +223.5% |
| FY2023 | $164.9K | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026